Cat-to-hedgehog xenotransfusion reported in anemic surgical case

Version 2 — Full analysis

A newly published case report describes what appears to be the first documented xenotransfusion of feline whole blood into an African pygmy hedgehog, used to support an anemic patient undergoing ovariohysterectomy. According to the report summary, the hedgehog was still anemic immediately after transfusion, but recovered well and reached a normal packed cell volume of 44% at the two-week recheck. The paper was published in Wiley's Journal of Veterinary Emergency and Critical Care by Hannah Kunzman, Sue Chen, Rebecca Salazar, and Heidi Hottinger. (onlinelibrary.wiley.com)

The case lands in a part of veterinary medicine where clinicians often have to improvise because species-specific evidence is thin. In dogs and cats, transfusion medicine is relatively mature. In hedgehogs and other exotic companion mammals, it's not. At the same time, reproductive tract disease is a significant issue in African pygmy hedgehogs. A 2025 study in Veterinarski arhiv found frequent uterine pathology in examined females and concluded that elective ovariohysterectomy should be considered as a preventive measure in this species. That broader disease burden helps explain why surgeons may encounter hedgehogs with anemia or reproductive pathology severe enough to force difficult perioperative decisions. (hrcak.srce.hr)

What makes this report stand out is not just the transfusion, but the donor species. Veterinary xenotransfusion literature has historically centered on canine blood given to cats in emergencies when compatible feline blood isn't available. Reviews and consensus guidance describe that approach as potentially lifesaving, but temporary: transfused donor red cells survive only a few days, delayed hemolytic reactions are common, and subsequent xenotransfusions after sensitization can trigger severe reactions, including death. The hedgehog case extends that conversation into exotic animal medicine, where the logistical barriers to finding a same-species donor can be even greater. (onlinelibrary.wiley.com)

The source abstract provides the key clinical takeaway: feline whole blood was used during surgery in an anemic hedgehog, post-transfusion anemia persisted initially, and recovery depended on the patient's own blood cell regeneration rather than a durable donor-cell effect. That pattern is consistent with what clinicians already know from other xenotransfusion settings, where the value is often short-term oxygen-carrying support rather than sustained hematologic correction. Because the full paper wasn't accessible through public indexing in this search, details such as crossmatching, transfusion volume, monitoring protocol, and perioperative complications weren't available here and would be important for clinicians to review in the original article before drawing practice conclusions. (onlinelibrary.wiley.com)

No independent expert commentary specific to this hedgehog report was readily available in public trade coverage at the time of this search. Still, published feline transfusion guidance offers a useful framework for interpretation. The AVHTM transfusion reaction consensus states that canine blood in cats should be used only as a last option and with informed consent, while ISFM guidance similarly frames xenotransfusion as a one-time emergency bridge when compatible species-matched blood isn't available. Extrapolating from cats to hedgehogs is imperfect, but the broader message is the same: xenotransfusion may buy time, yet it carries immunologic and practical limits. (onlinelibrary.wiley.com)

Why it matters: For emergency and exotic practitioners, this case underscores a familiar reality: the smallest, least-studied patients often present the biggest transfusion challenges. A hedgehog in hemorrhagic or severe anemic crisis may not have access to a validated donor pool, established blood typing system, or published compatibility data. In that context, a successful cat-to-hedgehog xenotransfusion offers proof of concept for a rescue strategy, not a new standard of care. Clinics considering a similar approach would still need to weigh donor availability, infectious disease screening, expected short red-cell lifespan, monitoring capacity, and the ethics and consent issues that come with using a cross-species blood product. (onlinelibrary.wiley.com)

The report also points to a research gap. Rabbit crossmatch work published in 2024 noted that xenotransfusion questions are increasingly relevant in species where allogeneic donors are scarce, and called for more prospective study of transfusion reactions and compatibility. Hedgehogs fit that pattern exactly. If more case reports emerge, the next step for the field will likely be basic compatibility work, followed by outcome tracking across exotic species and donor-recipient combinations. (onlinelibrary.wiley.com)

What to watch: Watch for publication of fuller technical details from this case, additional reports in hedgehogs or other exotic mammals, and any future guidance from emergency and transfusion medicine groups on when xenotransfusion is justified outside the better-studied dog-cat setting. (onlinelibrary.wiley.com)